Tigecycline and Pyogenic liver abscess - a phase IV clinical study of FDA data

Summary:

Pyogenic liver abscess is reported as a side effect among people who take Tigecycline (tigecycline), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Ceftazidime, and have Bacteraemia.

The phase IV clinical study analyzes which people have Pyogenic liver abscess when taking Tigecycline. It is created by eHealthMe based on reports of 3,945 people who have side effects when taking Tigecycline from the FDA, and is updated regularly.

What is Tigecycline?

Tigecycline has active ingredients of tigecycline. eHealthMe is studying from 3,946 Tigecycline users. Check the latest studies of Tigecycline.

What is Pyogenic liver abscess?

Pyogenic liver abscess (liver abscess caused by bacteria) is found to be associated with 397 drugs and 968 conditions by eHealthMe. Check the latest studies of Pyogenic liver abscess.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

3,945 people reported to have side effects when taking Tigecycline.
Among them, 21 people (0.53%) have Pyogenic liver abscess.

Could Tigecycline cause Pyogenic liver abscess?

Among these 21 people:

How long have people been on Tigecycline when they have Pyogenic liver abscess? *

What is the gender of people who have Pyogenic liver abscess when taking Tigecycline? *

female: 38.1 %
male: 61.9 %

What is the age of people who have Pyogenic liver abscess when taking Tigecycline? *

What are other drugs people take besides Tigecycline? *

What are other side effects people have besides Pyogenic liver abscess? *

Bacteraemia (presence of bacteria in the blood): 12 people, 57.14%
Hepatic Infarction (particular area of the liver has lost its blood supply and died): 8 people, 38.10%
Endocarditis (inflammation in heart muscle): 8 people, 38.10%
Splenic Abscess (pus in spleen or near by): 8 people, 38.10%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 8 people, 38.10%
Renal Infarct (kidney damage due to lack of blood supply): 8 people, 38.10%
Renal Abscess (pus in kidney): 8 people, 38.10%
Intestinal Ischaemia (decreased supply of oxygenated blood to the intestines): 8 people, 38.10%
Pathogen Resistance: 8 people, 38.10%
Peritoneal Haemorrhage (peritoneal bleeding): 7 people, 33.33%

What are the existing conditions these people have? *

Bacteraemia (presence of bacteria in the blood): 7 people, 33.33%
Immunodeficiency Disorders: 4 people, 19.05%
Pelvic Abscess: 1 person, 4.76%
Drug Dependence: 1 person, 4.76%
Depression: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Tigecycline and have Pyogenic liver abscess?

- Check whether Pyogenic liver abscess is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tigecycline:

Tigecycline (3,946 reports)

Browse all side effects of Tigecycline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pyogenic liver abscess:

Pyogenic liver abscess (397 drugs)

Browse all the conditions that are associated with Pyogenic liver abscess:

Pyogenic liver abscess (968 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tigecycline (the active ingredients of Tigecycline) and Tigecycline (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.